Literature DB >> 21427642

Early and late-onset effect of chronic stress on vascular function in mice: a possible model of the impact of depression on vascular disease in aging.

Elsa Isingrini1, Catherine Belzung, Alexandre d'Audiffret, Vincent Camus.   

Abstract

Depression is recognized as a predictor of increased cardiac morbidity and mortality. In addition, depressed patients exhibit an increase in the serum markers of endothelial dysfunction and platelet activation involved in the cascade of events leading to atherosclerosis. The purpose of this study was to determine the early and late-onset expression of various vascular markers in a rodent model of depression. Male DBA (an inbred strain of mice)/2J mice were exposed to either 7 weeks of controlled living conditions or unpredictable chronic mild stress (UCMS), and subsequently given daily fluoxetine (10 mg/kg) or NaCl (9%) during the last 5 weeks of the experiment. Depressive-like behavior was evaluated by using motivational and self-care behavior, including the assessment of the animal's coat state and grooming behavior. Enzyme-linked immunoassay was used to quantify matrix metalloproteinase-9 (MMP-9), vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and plasminogen activator inhibitor-1 (PAI-1) expression either immediately after the end of the UCMS procedure (short term condition) or 10 months later (long-term condition). Results indicate that 1) UCMS procedure induces a short-term depressive-like behavior in mice, defined as coat state deterioration, an effect that is prevented by fluoxetine treatment; 2) UCMS procedure has no effect on the short-term expression of the studied markers; however, UCMS increases expression of plasminogen activator inhibitor-1 only in the long-term group; 3) fluoxetine treatment is unable to counteract this UCMS-induced change; 4) aging induces behavioral perturbation, defined as a decrease in grooming motivation, and an increase of all the vascular markers in both control and UCMS groups and 5) pretreatment with fluoxetine has no protective effects on aging-induced behavioral and vascular alterations. Thus, in this model of depression-like behavior, UCMS appears to induce late-onset physiological changes, which are consistent with human studies indicating that depression is a risk factor for the development of heart disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21427642     DOI: 10.1097/JGP.0b013e318202bc42

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  9 in total

1.  Anxiety disorders: new developments in old age.

Authors:  Eric J Lenze; Julie Loebach Wetherell
Journal:  Am J Geriatr Psychiatry       Date:  2011-04       Impact factor: 4.105

2.  Potential translational targets revealed by linking mouse grooming behavioral phenotypes to gene expression using public databases.

Authors:  Andrew Roth; Evan J Kyzar; Jonathan Cachat; Adam Michael Stewart; Jeremy Green; Siddharth Gaikwad; Timothy P O'Leary; Boris Tabakoff; Richard E Brown; Allan V Kalueff
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-10-31       Impact factor: 5.067

3.  Protection from vascular dysfunction in female rats with chronic stress and depressive symptoms.

Authors:  Steven D Brooks; Stanley M Hileman; Paul D Chantler; Samantha A Milde; Kent A Lemaster; Stephanie J Frisbee; J Kevin Shoemaker; Dwayne N Jackson; Jefferson C Frisbee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-16       Impact factor: 4.733

4.  Vascular depression consensus report - a critical update.

Authors:  Howard J Aizenstein; Andrius Baskys; Maura Boldrini; Meryl A Butters; Breno S Diniz; Manoj Kumar Jaiswal; Kurt A Jellinger; Lev S Kruglov; Ivan A Meshandin; Milija D Mijajlovic; Guenter Niklewski; Sarah Pospos; Keerthy Raju; Kneginja Richter; David C Steffens; Warren D Taylor; Oren Tene
Journal:  BMC Med       Date:  2016-11-03       Impact factor: 8.775

5.  Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments.

Authors:  Hélène Party; Cléo Dujarrier; Marie Hébert; Sophie Lenoir; Sara Martinez de Lizarrondo; Raphaël Delépée; Claudine Fauchon; Marie-Christine Bouton; Pauline Obiang; Olivier Godefroy; Etienne Save; Laurent Lecardeur; Joëlle Chabry; Denis Vivien; Véronique Agin
Journal:  Acta Neuropathol Commun       Date:  2019-10-14       Impact factor: 7.801

6.  Effects of Kaixinjieyu, a Chinese herbal medicine preparation, on neurovascular unit dysfunction in rats with vascular depression.

Authors:  Juhua Pan; Xiaoming Lei; Jialong Wang; Shijing Huang; Yanyun Wang; Ying Zhang; Wen Chen; Duojiao Li; Jun Zheng; Hanming Cui; Qihua Liu
Journal:  BMC Complement Altern Med       Date:  2015-08-19       Impact factor: 3.659

7.  Expression and Activity of Metalloproteinases in Depression.

Authors:  Kinga Bobińska; Janusz Szemraj; Piotr Czarny; Piotr Gałecki
Journal:  Med Sci Monit       Date:  2016-04-21

Review 8.  Off-Target Effects of Antidepressants on Vascular Function and Structure.

Authors:  Anna Dimoula; Dimitrios Fotellis; Evmorfia Aivalioti; Dimitrios Delialis; Alexia Polissidis; Raphael Patras; Nikolaos Kokras; Kimon Stamatelopoulos
Journal:  Biomedicines       Date:  2021-12-28

9.  Statins Mitigate Stress-Related Vascular Aging and Atherosclerosis in apoE-Deficient Mice Fed High Fat-Diet: The Role of Glucagon-Like Peptide-1/Adiponectin Axis.

Authors:  Yanna Lei; Qingsong Cui; Guang Yang; Limei Piao; Aiko Inoue; Hongxian Wu; Xiang Li; Masafumi Kuzuya; Xian Wu Cheng
Journal:  Front Cell Dev Biol       Date:  2021-07-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.